Topics Covered:
• Simcyp Ethinyl Estradiol model
• Development of Progestin models
• DDI studies with Oral Contraceptives
• Future perspectives
Certara accelerates medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.
Please visit us at www.certara.com/